Cytena

About:

Cytena develops single-cell printing technology for cell research and professional diagnostics.

Website: http://www.cytena.com/

Twitter/X: cytena

Top Investors: HTGF | High-Tech Gruenderfonds, VentureOut

Description:

cytena GmbH has developed a device called cy-Clone to separate single cells. Single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research. The cy-Clone is supported by an automated imaging process to encapsulate cells in droplets, which are delivered to any type of substrate. Thanks to this particularly gentle delivery method, the cells are able to survive post printing and can either be analyzed thereafter or grown into clonal colonies. To determine clonality, multiple images are recorded during the process. Cross-contamination is avoided by the use of disposable parts.